#2017596
Ocsaimil
Oxamyl
Scag na torthaí
Bailiúcháin
43 toradh in 15 doiciméad
#2154346
OCSAIMIL
OXAMYL
#2359176
Ocsaimil
Oxamyl
#2739949
Ocsaimil
Oxamyl
#2743261
Dá bhrí sin, is iomchuí gan formheas na substainte gníomhaí ocsaimil a athnuachan.
It is therefore appropriate not to renew the approval of the active substance oxamyl.
#2743272
Ní dhéantar formheas na substainte gníomhaí ocsaimil a athnuachan.
The approval of the active substance oxamyl is not renewed.
#3206770
Ocsaimil
Oxamyl
#3207076
Chuaigh formheas na substainte gníomhaí ocsaimil in éag an 1 Bealtaine 2023.
The approval of the active substance oxamyl expired on 1 May 2023.
#3251629
Ocsaimil
Oxamyl
#1914811
sa séú colún, dul in éag an fhormheasa, de ró 116, Ocsaimil, cuirtear “31 Eanáir 2022” in ionad an dáta;
in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2022’;
#2161314
sa séú colún, dul in éag an fhormheasa, de ró 116, Ocsaimil, cuirtear “31 Eanáir 2023” in ionad an dáta;
in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2023’;
#2705708
Le Rialachán Cur Chun Feidhme (AE) 2021/2068 ón gCoimisiún cuireadh síneadh le tréimhse formheasa na substainte gníomhaí ocsaimil go dtí an 31 Eanáir 2023.
Commission Implementing Regulation (EU) 2021/2068 extended the approval period of the active substance oxamyl until 31 January 2023.
#2705709
Cuireadh isteach iarratas ar fhormheas na substainte gníomhaí ocsaimil a athnuachan i gcomhréir le Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012 ón gCoimisiún.
An application for the renewal of the approval of the active substance oxamyl was submitted in accordance with Commission Implementing Regulation (EU) No 844/2012.
#2705731
Conclusion on the peer review of the pesticide risk assessment of the active substance oxamyl [Conclúid maidir leis an athbhreithniú piaraí ar an measúnú riosca lotnaidicídí ar an tsubstaint ghníomhach ocsaimil].
Conclusion on the peer review of the pesticide risk assessment of the active substance oxamyl.
#2743241
Le Treoir 2006/16/CE ón gCoimisiún áirítear ocsaimil mar shubstaint ghníomhach in Iarscríbhinn I a ghabhann le Treoir 91/414/CEE ón gComhairle.
Commission Directive 2006/16/EC included oxamyl as an active substance in Annex I to Council Directive 91/414/EEC.
#2743263
Ba cheart am leordhóthanach a thabhairt do na Ballstáit údaruithe maidir le táirgí cosanta plandaí ina bhfuil ocsaimil a tharraingt siar.
Member States should be given sufficient time to withdraw authorisations for plant protection products containing oxamyl.
#2743278
Déanfaidh na Ballstáit na húdaruithe a tharraingt siar maidir le táirgí cosanta plandaí ina bhfuil ocsaimil mar shubstaint ghníomhach faoin 30 Meitheamh 2023.
Member States shall withdraw authorisations for plant protection products containing oxamyl as an active substance by 30 June 2023.
#3206735
I gcás na substainte gníomhaí ocsaimil, socraíodh uasleibhéil iarmhar (‘MRLanna’) in Iarscríbhinn II a ghabhann le Rialachán (CE) Uimh. 396/2005.
For the active substance oxamyl, maximum residue levels (‘MRLs’) were set in Annex II to Regulation (EC) No 396/2005.
#1914777
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin
#1914784
Le Rialachán Cur Chun Feidhme (AE) 2019/2094 ón gCoimisiún, cuireadh síneadh go dtí an 31 Eanáir 2021 le tréimhse formheasa na substaintí gníomhacha démhocsastróibin, meiceapróp-P, meitiream, ocsaimil agus pireaclóstróibin, agus síneadh go dtí an 28 Feabhra 2021 le tréimhse formheasa na substaintí gníomhacha beanflurailin, fluasanam, flutolainil agus meipiocuat.
Commission Implementing Regulation (EU) 2019/2094 extended the approval period of the active substances dimoxystrobin, mecoprop-P, metiram, oxamyl and pyraclostrobin until 31 January 2021, and the approval period of the active substances benfluralin, fluazinam, flutolanil and mepiquat until 28 February 2021.
#1914804
Rialachán Cur Chun Feidhme (AE) 2019/2094 ón gCoimisiún an 29 Samhain 2019 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, mancóiseib, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin (IO L 317, 9.12.2019, lch. 102).
Commission implementing Regulation (EU) 2019/2094 of 29 November 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (OJ L 317, 9.12.2019, p. 102).
#2161278
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin
#2161285
Le Rialachán Cur Chun Feidhme (AE) 2021/52 ón gCoimisiún, cuireadh síneadh go dtí an 31 Eanáir 2022 le tréimhse formheasa na substaintí gníomhacha démhocsastróibin, meiceapróp-P, meitiream, ocsaimil agus pireaclóstróibin, agus síneadh go dtí an 28 Feabhra 2022 le tréimhse formheasa na substaintí gníomhacha beanflurailin, fluasanam, flutolainil agus meipiocuat.
Commission Implementing Regulation (EU) 2021/52 extended the approval period of the active substances dimoxystrobin, mecoprop-P, metiram, oxamyl and pyraclostrobin until 31 January 2022, and the approval period of the active substances benfluralin, fluazinam, flutolanil and mepiquat until 28 February 2022.
#2161306
Rialachán Cur Chun Feidhme (AE) 2021/52 ón gCoimisiún an 22 Eanáir 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin (IO L 23, 25.1.2021, lch. 13).
Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (OJ L 23, 25.1.2021, p. 13).
#2658674
Rialachán Cur Chun Feidhme (AE) 2019/2094 ón gCoimisiún an 29 Samhain 2019 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanfluarailin, démhocsastróibin, fluasanam, flutolainil, mancóiseib, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2019/2094 of 29 November 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin is to be incorporated into the EEA Agreement.
#2705638
Rialachán Cur Chun Feidhme (AE) 2021/2068 ón gCoimisiún an 25 Samhain 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin (IO L 421, 26.11.2021, lch. 25).
Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (OJ L 421, 26.11.2021, p. 25).
#2705694
Rialachán Cur Chun Feidhme (AE) 2021/2068 ón gCoimisiún an 25 Samhain 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin (IO L 421, 26.11.2021, lch. 25).
Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (OJ L 421, 26.11.2021, p. 25).
#2705701
lena leasaítear Rialacháin Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhse formheasa na substainte gníomhaí ocsaimil
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance oxamyl
#2705710
Cé go bhfuil an chonclúid ón Údarás Eorpach um Shábháilteacht Bia ar fáil maidir leis an meastóireacht ar an tsubstaint ghníomhach ocsaimil agus gur thionscain an Coimisiún pléití ag an mBuanchoiste um Plandaí, Ainmhithe, Bia agus Beatha, dealraíonn sé mar sin féin gur dócha go rachaidh an formheas in éag sula mbeidh cinneadh déanta maidir leis an athnuachan.
Although the European Food Safety Authority’s conclusion on the evaluation of the active substance oxamyl is available and the Commission has initiated discussions at the Standing Committee on Plants, Animals, Food and Feed, it still appears that the approval is likely to expire before a decision has been taken on renewal.
#2705719
I gCuid A den Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011, sa séú colún “Dul in éag an fhormheasa” d’iontráil 116, Ocsaimil, cuirtear “31 Deireadh Fómhair 2023” in ionad an dáta.
In Part A of the Annex to Implementing Regulation (EU) No 540/2011, in the sixth column, ‘Expiration of approval’, of entry 116, Oxamyl, the date is replaced by ‘31 October 2023’.
#2705728
Rialachán Cur Chun Feidhme (AE) 2021/2068 ón gCoimisiún an 25 Samhain 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin (IO L 421, 26.11.2021, lch. 25).
Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (OJ L 421, 26.11.2021, p. 25).
#2743235
maidir le neamh-athnuachan ar fhormheas na substainte gníomhaí ocsaimil, i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle, agus lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún
concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
#2743243
Formheas na substainte gníomhaí ocsaimil, mar a leagtar amach i gCuid A den Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011, rachaidh sé in éag an 31 Deireadh Fómhair 2023.
The approval of the active substance oxamyl, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 31 October 2023.
#2743244
Cuireadh iarratas faoi bhráid na hIodáile, an Ballstát is rapóirtéir, agus faoi bhráid na Fraince, an Ballstáit is comhrapóirtéir, chun formheas na substainte gníomhaí ocsaimil a athnuachan, i gcomhréir le hAirteagal 1 de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012 ón gCoimisiún agus laistigh den tréimhse ama dá bhforáiltear san Airteagal sin.
An application for the renewal of the approval of the active substance oxamyl was submitted to Italy, the rapporteur Member State, and France, the co-rapporteur Member State, in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 within the time period provided for in that Article.
#2743251
An 30 Márta 2022, chuir an tÚdarás a chonclúid in iúl don Choimisiún i dtaobh an féidir coinne a bheith leis go gcomhlíonfaidh ocsaimil na critéir formheasa dá bhforáiltear in Airteagal 4 de Rialachán (CE) Uimh. 1107/2009.
On 30 March 2022, the Authority communicated to the Commission its conclusion on whether oxamyl can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
#2743264
Maidir le táirgí cosanta plandaí ina bhfuil ocsaimil, i gcás ina ndeonóidh na Ballstáit aon tréimhse chairde i gcomhréir le hAirteagal 46 de Rialachán (CE) Uimh. 1107/2009, ba cheart an tréimhse sin dul in éag, ar a dhéanaí, an 30 Meán Fómhair 2023.
For plant protection products containing oxamyl, where Member States grant any grace period in accordance with Article 46 of Regulation (EC) No 1107/2009, that period should at the latest, expire on 30 September 2023.
#2743267
Leis an Rialachán seo, ní chuirtear cosc ar iarratas eile a chur isteach maidir leis an tsubstaint ghníomhach ocsaimil a fhormheas de bhun Airteagal 7 de Rialachán (CE) Uimh. 1107/2009.
This Regulation does not prevent the submission of a further application for the approval of oxamyl pursuant to Article 7 of Regulation (EC) No 1107/2009.
#2743290
Treoir 2006/16/CE ón gCoimisiún an 7 Feabhra 2006 lena leasaítear Treoir 91/414/CEE ón gComhairle chun ocsaimil a áireamh mar shubstaint ghníomhach (IO L 36, 8.2.2006, lch. 37).
Commission Directive 2006/16/EC of 7 February 2006 amending Council Directive 91/414/EEC to include oxamyl as active substance (OJ L 36, 8.2.2006, p. 37).
#2743296
Rialachán Cur Chun Feidhme (AE) 2023/116 ón gCoimisiún an 16 Eanáir 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhse formheasa na substainte gníomhaí ocsaimil (IO L 15, 17.1.2023, lch. 15).
Commission Implementing Regulation (EU) 2023/116 of 16 January 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance oxamyl (OJ L 15, 17.1.2023, p. 15).
#2778015
Rialachán Cur Chun Feidhme (AE) 2021/2068 ón gCoimisiún an 25 Samhain 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin, tá sé le hionchorprú i gcomhaontú LEE.
Commission Implementing Regulation (EU) 2021/2068 of 25 November 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin is to be incorporated into the EEA Agreement.
#3097720
Rialachán Cur Chun Feidhme (AE) 2021/52 ón gCoimisiún an 22 Eanáir 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beanflurailin, démhocsastróibin, fluasanam, flutolainil, meiceapróp-P, meipiocuat, meitiream, ocsaimil agus pireaclóstróibin, tá sé le hionchorprú i gcomhaontú LEE.
Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin is to be incorporated into the EEA Agreement.
#3206759
Rialachán Cur Chun Feidhme (AE) 2023/741 ón gCoimisiún an 5 Aibreán 2023 maidir le neamh-athnuachan ar fhormheas na substainte gníomhaí ocsaimil, i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle, agus lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún (IO L 98, 11.04.2023, lch. 1)
Commission Implementing Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 98, 11.4.2023, p. 1).
#3207078
An tÚdarás Eorpach um Shábháilteacht Bia; Conclusion on the peer review of the pesticide risk assessment of the active substance oxamyl (‘Conclúid maidir leis an athbhreithniú piaraí ar an measúnú riosca lotnaidicídí ar an tsubstaint ghníomhach ocsaimil’]. EFSA Journal [Iris EPSA] 2022;20(5):7296.
European Food Safety Authority; Conclusion on the peer review of the pesticide risk assessment of the active substance oxamyl. EFSA Journal 2022;20(5):7296.